498 Adalimumab Trough Serum Levels and Clinical Response in a Single-Center Cohort of Inflammatory Bowel Disease Patients: Can Trough Serum Levels Serve As a Predictor for Future Loss of Response?

✍ Scribed by Konstantinos Karmiris; Gilles Paintaud; Danielle Degenne; Marc Ferrante; Anne-Claire Duveau; Maja Noman; Gert A. Van Assche; Severine Vermeire; Paul Rutgeerts

• Book ID: 119428197
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 69 KB
• Volume: 134
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(08)60322-4